Ces recommandations temporaires sont émises à l’intention des États Parties qui font face à une transmission du virus de la mpox (MPXV), y compris, sans que cette liste soit exhaustive, ceux touchés par une transmission communautaire persistante et ceux où l’on observe des groupes de cas o...u des cas sporadiques d’infection par le clade Ib du MPXV liés à des voyages.
more
This interim operational guide outlines infection prevention, control, and water, sanitation, and hygiene measures for home care and isolation of mpox in resource-limited settings. It focuses on practical strategies to manage and prevent the spread of the virus when persons with mpox are isolated at... home in settings with limited resources. This document is intended for health and care workers, caregivers, and public health authorities.
more
This practical guideline establishes definitions for “contact”, “contact person”, “contact tracing” and other associated concepts. It allows for improvement of contact tracing strategies and provides recommendations attempting to answer some, though not all, questions that arose during t...he 2019 coronavirus pandemic and other outbreaks. The use of this guideline begins once people have been diagnosed and the potential for transmission exists. It is not, however, intended to assist with case investigation. The guideline empowers health workers, governments, and public health officials with the tools to implement effective contact tracing strategies.
more
The rapid assessment tool (RAT) is meant to assess health facilities within mpox-affected areas that have at least one inpatient bed. Depending on time and resources available, certain facilities may be prioritized during an mpox outbreak. The RAT evaluates 16 infection prevention and control (IPC) ...and water, sanitation and hygiene (WASH) criteria identified as the minimum essential elements required for safe patient care and prevention of transmission within the health facility during readiness or response activities for outbreaks of mpox.
more
On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedi...cal Center and were positive for Marburg virus. As of 29 September 2024, a total of 26 confirmed cases, including eight deaths have been reported. The cases are reported from seven of the 30 districts in the country. Among the confirmed cases, over 70% are healthcare workers from two health facilities in Kigali.
more
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...All recorded MVD
outbreaks to date have originated in Africa. MVD is not an airborne disease and is considered not to be
contagious before symptoms appear. Direct contact with the blood and other body fluids of infected people
and animals or indirect contact with contaminated surfaces and materials like clothing, bedding and medical
equipment is required for transmission. The risk of infection is minimised when proper infection prevention and
control precautions are strictly followed. There is no approved treatment or vaccine for MVD; however, several
pharmaceuticals and candidate MVD vaccines are under investigation.
more
Le 14 août, l’Organisation mondiale de la Santé (OMS) déclarait que l’épidémie de variole simienne, dite Mpox, était une « urgence sanitaire internationale », après une flambée des cas en Afrique. Le lendemain, un cas était déclaré en Suède. La branche européenne de l’OMS estime... que d’autres cas importés de Mpox sont susceptibles d’être détectés prochainement en Europe. Ce qu’il faut savoir sur cette épidémie.
more
The safety of children is a top concern for parents and school authorities in the current mpox outbreak, as those
under 15 face elevated risks, particularly in the hardesthit Northwestern and Eastern regions of the Democratic Republic of the Congo.
On 27 September 2024, the Ministry of Health of Rwanda confirmed the country’s first outbreak of Marburg virus disease (MVD), with health-care workers in Kigali particularly affected. While sporadic outbreaks have occurred in various parts of Africa since the first recognized cases in 1967, this o...utbreak is the third largest outbreak of MVD ever recorded to date. Marburg virus disease is a severe disease clinically similar to Ebola disease. With no approved treatments or vaccines for MVD, early intervention for those showing symptoms is crucial for improving survival rates.
more
La République démocratique du Congo (RDC) mise sur la surveillance communautaire pour mieux riposter à la variole simienne appelée en anglais Mpox. En 2023, plus de 14 000 cas de Mpox ont été détectés. Le pays, avec l’appui de ses partenaires, forme les relais communautaires pour la sensib...ilisation de la population sur l’importance de se rendre rapidement à l’hôpital dès les premiers symptômes.
more
Uganda confirmed the first cases of mpox on 24 July 2024 following the confirmation of two case-patients from Kasese District, Bwera Hospital by the Uganda Virus Research Institute (UVRI) through a routine sentinel surveillance system. Cumulatively, 80 confirmed cases of mpox have been registered.
The tab is the result of a preliminary landscape of therapeutics licensed or under development for Mpox
There has been a global outbreak of mpox since 2022; this outbreak has been caused by the strain of mpox virus called Clade 2 and has affected around 116 countries worldwide. The current surge in cases is being driven by the rapid spread of a different strain – Clade 1b – which is predominantly ...affecting countries across the African region, particularly DRC, Burundi, Kenya, Uganda and Rwanda [1]. The guidance in this document applies to both Clades of mpox. WHO publishes a dashboard of updated cases globally here. Different Clades and Sub-Clades of mpox behave slightly differently to each other; WHO is monitoring for any significant differences between the Clades, including transmission routes. This guidance will be updated as more information becomes available on this issue.
more
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers, and partners to plan and implement readiness and response activities for dengue fever outbreaks. The toolkit conta...ins: information about dengue fever; RCCE considerations for how to approach key issues during dengue fever outbreaks; tools for understanding the context in which dengue fever outbreaks occur; methods for collecting data to inform strategy development and bring evidence into planning and implementation of activities; guidance to support vector control and prevention activities; case studies; and links to existing RCCE tools and training. It is one of a suite of toolkits on RCCE readiness and response to a range of disease and response areas.
more
interim guidance, 25 November 2024
This is the 35th situation report for the multi-country outbreak of mpox, which provides details on the latest epidemiological trends, including an update on the geographic expansion of mpox in the WHO African Region from July – August 2024.
On 14 August 2024, the Director-General of the World Health Organization determined that the upsurge of mpox in a growing number of countries in Africa constitutes a new public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005)
Du 09 janvier au 08 avril 2024, le Congo a confirmé 19 cas de Mpox dans 04 départements, à savoir : 14 cas dans la Cuvette, 02 cas dans la Likouala, 02 cas dans les Plateaux et 01 cas à Pointe-Noire. Au regard de cette situation, le Gouvernement de la République, via le Ministère de la Santé ...et de la Population, a déclaré, en date du 23 avril 2024, l’épidémie de Mpox conduisant à l’activation du COUSP1 en date du 03 mai 2024 avec la mise en place du Système de Gestion d’Incident (SGI) assorti de toutes ses fonctions essentielles et élargies sous l’approche « Une Seule Santé ». A la 39ème semaine épidémiologique, 1 nouveau cas a été confirmé par le LNSP2 dans le département de Brazzaville, DS de Madibou, dans l’aire de santé de Mansimou, donnant un total de 22 cas confirmés.
more